<DOC>
	<DOCNO>NCT02875652</DOCNO>
	<brief_summary>Quantification follow-up 3 year circulate tumoral DNA patient choroidal melanoma</brief_summary>
	<brief_title>Circulating Tumoral DNA Choroidal Melanoma ( ctDNA MU )</brief_title>
	<detailed_description>This study prospective , open-labelled , monocentric trial . The aim observe , patient choroidal melanoma ( stage disease ) , prevalence circulate tumor DNA diagnostic evolution 3 year . The patient blood sample follow time : - T0 : treatment primary tumor . - T1 : 1 month end local treatment . - T2 : 7 month . - Tn : every 6 month 3 year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>Aged 18 year old . Patient recent choroidal melanoma start specific treatment . Patient able stand blood collection . Workup extension ( CT ) . Patient explanation give consent information sign legal representative Patient without social protection / insurance . Person deprive liberty guardianship . Inability submit medical monitoring trial reason geography , social psychological</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>circulation tumor DNA</keyword>
	<keyword>choroidal melanoma</keyword>
</DOC>